ATA Vaccine Preparation Therapy utilizes autologous cell vaccines derived from a patient’s circulating tumor cells (CTCs) to stimulate the immune system’s response against cancer cells. By harnessing the body’s natural defenses, this innovative therapy offers a personalized approach to cancer treatment.
The vaccine is prepared using antigens extracted from the patient’s Circulating Tumor Cells (CTCs).
The antigens can stimulate the immune system to recognize and attack cancer cells effectively.
When it’s administered into the body, the vaccine triggers an immune response, targeting and eliminating cancer cells.
ATA therapy – looks for – Tumor cells fragments – helps in developing autologous cell vaccine from patient’s tumor cells.
Patients may consider ATA Therapy when conventional treatment options are not working for their specific cancer.
Whether the disease is stable, or the patient is at risk of recurrence, this therapy offers an advanced approach to cancer treatment.
The therapy has demonstrated proven efficacy in treating cancer with durable tumor regressions and progression-free survival.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
“RGCC’s ChemoSNiP test guides my treatment decisions with precision. It helps me tailor chemotherapy regimens to each patient’s genetic profile, improving efficacy and minimizing side effects. It’s an essential tool in personalized cancer care.”
Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.
Requires 20-30 ml of blood sample
Patients need to avoid chemotherapy, targeted therapies, radiation, IVs, and Ozone therapy 7 days before ATA VACCINE administration.
Patients should not be on immune suppression therapy up to 45 days prior to the application of ATA VACCINE.
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.
Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells. Once testing is complete, your sample is stored for up to six months in case further analysis is needed.
Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.
Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.
RGCC tests like Metastat accurately detect the development of secondary tumors.
Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.
Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.
Indeed, tests are designed to reveal whether cancer cells are resistant or sensitivity to specific drugs and treatments.
Exhausted from trying various cancer treatments? Consider ATA therapy. It activates and stimulates the immune system to effectively targets cancer cells. Whether it’s active cancer or recurrence, ATA therapy offers promising results. Embrace a treatment that works best for your cancer!
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
Copyright 2024 © All Right Reserved.
Designed by Bee High Media